These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4421027)

  • 21. Studies on the stability and compatibility of drugs in infusion fluids. VI. Factors affecting the stability of ampicillin.
    Stjernström G; Olson OT; Nyqvist H; Lundgren P
    Acta Pharm Suec; 1978; 15(1):33-50. PubMed ID: 25558
    [No Abstract]   [Full Text] [Related]  

  • 22. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems of administering drugs by continuous infusion.
    Brodlie P; Henney C; Wood AJ
    Br Med J; 1974 Mar; 1(5904):383-5. PubMed ID: 4819177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The problem of physico-chemical and pharmacological incompatibility of the products used in phleboclysis in resuscitation].
    Arosio G; Mazzardi E; Bellini L; Rastrelli GF
    Minerva Anestesiol; 1976 Apr; 42(4):245-60. PubMed ID: 1018767
    [No Abstract]   [Full Text] [Related]  

  • 25. Stability of parenteral solutions of tobramycin sulfate.
    Bergstrom RF; Fites AL; Lamb JW
    Am J Hosp Pharm; 1975 Sep; 32(9):887-8. PubMed ID: 242216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ; Ueda CT; Newton DW
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of cefamandole nafate injection with parenteral solutions and additives.
    Frable RA; Klink PR; Engel GL; Mundell EE
    Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on stability testing in pharmaceutical formulation.
    Lundgren P
    Acta Pharm Suec; 1971 Jun; 8(3):169-92. PubMed ID: 5314840
    [No Abstract]   [Full Text] [Related]  

  • 31. A stability and compatibility evaluation of a novel calcium entry blocker in admixture preparations.
    Kishnani NS; Visor GC
    J Parenter Sci Technol; 1988; 42(2):68-71. PubMed ID: 3385545
    [No Abstract]   [Full Text] [Related]  

  • 32. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.
    Williams DA; Lokich J
    Cancer Chemother Pharmacol; 1992; 31(3):171-81. PubMed ID: 1464154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 34. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 35. Remarks about and prospects of the use of antibiotics in hospitals.
    Rondanelli R; Guaglio R; Leonardi V; Cristiani D
    Prog Clin Biol Res; 1979; 35():203-10. PubMed ID: 538033
    [No Abstract]   [Full Text] [Related]  

  • 36. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 37. [The osmolarity and incompatibility of solutions for injections and infusions].
    Borzunov EE; Korytniuk RS; Shumilo TV; Torkhova TV
    Vrach Delo; 1990 Nov; (11):98-9. PubMed ID: 2098999
    [No Abstract]   [Full Text] [Related]  

  • 38. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug compatibility and incompatibility in infusion solutions].
    Viering HD
    Infusionstherapie (1973); 1973 Oct; 1(1):74. PubMed ID: 4806247
    [No Abstract]   [Full Text] [Related]  

  • 40. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.